25 XP   0   0   10

China Resources Sanjiu Medical & Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse China Resources Sanjiu Medical & Pharmaceutical Co Ltd together

PenkeI guess you are interested in China Resources Sanjiu Medical & Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of China Resources Sanjiu Medical & Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about China Resources Sanjiu Medical & Pharmaceutical Co Ltd

I send you an email if I find something interesting about China Resources Sanjiu Medical & Pharmaceutical Co Ltd.

Quick analysis of China Resources Sanjiu Medical & Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of China Resources Sanjiu Medical & Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.15
When do you have the money?
1 year
How often do you get paid?
97.5%

What is your share worth?

Current worth
¥23.91
Expected worth in 1 year
¥30.74
How sure are you?
97.5%

+ What do you gain per year?

Total Gains per Share
¥7.91
Return On Investment
15.0%

For what price can you sell your share?

Current Price per Share
¥52.73
Expected price per share
¥47.35 - ¥59.00
How sure are you?
50%

1. Valuation of China Resources Sanjiu Medical & Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥52.73

Intrinsic Value Per Share

¥22.88 - ¥57.70

Total Value Per Share

¥46.79 - ¥81.61

2. Growth of China Resources Sanjiu Medical & Pharmaceutical Co Ltd (5 min.)




Is China Resources Sanjiu Medical & Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$3.2b$2.2b$754.7m25.0%

How much money is China Resources Sanjiu Medical & Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$100.3m$78.1m$22.1m22.1%
Net Profit Margin11.7%13.8%--

How much money comes from the company's main activities?

3. Financial Health of China Resources Sanjiu Medical & Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of China Resources Sanjiu Medical & Pharmaceutical Co Ltd? (5 min.)

Welcome investor! China Resources Sanjiu Medical & Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of China Resources Sanjiu Medical & Pharmaceutical Co Ltd.

What can you expect buying and holding a share of China Resources Sanjiu Medical & Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of China Resources Sanjiu Medical & Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of China Resources Sanjiu Medical & Pharmaceutical Co Ltd is ¥52.73. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of China Resources Sanjiu Medical & Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in China Resources Sanjiu Medical & Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥23.91. Based on the TTM, the Book Value Change Per Share is ¥1.71 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.38 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.27 per quarter.
Based on historical numbers we can estimate the returns while holding a share of China Resources Sanjiu Medical & Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.070.1%0.100.2%0.080.1%0.080.1%0.060.1%
Usd Book Value Change Per Share0.090.2%0.240.4%0.050.1%0.090.2%0.060.1%
Usd Dividend Per Share0.000.0%0.040.1%0.030.1%0.020.0%0.020.0%
Usd Total Gains Per Share0.100.2%0.270.5%0.080.2%0.110.2%0.080.2%
Usd Price Per Share6.94-7.44-5.64-4.90-4.22-
Price to Earnings Ratio23.56-19.96-19.50-27.07-24.15-
Price-to-Total Gains Ratio72.88-55.84--0.78-97.38-83.68-
Price to Book Ratio2.10-2.45-2.46-2.21-2.63-
Price-to-Total Gains Ratio72.88-55.84--0.78-97.38-83.68-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.297832
Number of shares137
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.02
Usd Book Value Change Per Share0.240.09
Usd Total Gains Per Share0.270.11
Gains per Quarter (137 shares)37.5015.37
Gains per Year (137 shares)150.0161.50
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
121129140124951
2412592902598112
36238844037147173
48251859050196234
510364774062246295
612377789074295356
7144906104087344417
81641036119099393478
918511651340112442539
1020512951490124491600

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%84.00.02.097.7%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%18.02.00.090.0%35.05.00.087.5%72.014.00.083.7%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.00.01.097.5%76.00.010.088.4%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%19.01.00.095.0%39.01.00.097.5%82.04.00.095.3%

Fundamentals of China Resources Sanjiu Medical & Pharmaceutical Co Ltd

About China Resources Sanjiu Medical & Pharmaceutical Co Ltd

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in the People's Republic of China and internationally. It also provides related health services. The company offers OTC products, including cold, skin, gastrointestinal, cough, orthopedics, and pediatrics drugs; prescription drug products in traditional Chinese medicine, tumors, cardiovascular and cerebrovascular, digestive system, orthopedics, and pediatrics; Chinese medicine injections; formula granules; and anti-infective drugs. The company was formerly known as Sanjiu Pharmaceutical Co., Ltd. and changed its name to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. in February 2010. The company was founded in 1999 and is based in Shenzhen, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-03-23 21:21:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of China Resources Sanjiu Medical & Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit China Resources Sanjiu Medical & Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare China Resources Sanjiu Medical & Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 9.6% means that ¥0.10 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of China Resources Sanjiu Medical & Pharmaceutical Co Ltd:

  • The MRQ is 9.6%. The company is making a profit. +1
  • The TTM is 11.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ9.6%TTM11.7%-2.1%
TTM11.7%YOY13.8%-2.2%
TTM11.7%5Y13.4%-1.8%
5Y13.4%10Y13.5%0.0%
1.1.2. Return on Assets

Shows how efficient China Resources Sanjiu Medical & Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare China Resources Sanjiu Medical & Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.4% Return on Assets means that China Resources Sanjiu Medical & Pharmaceutical Co Ltd generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of China Resources Sanjiu Medical & Pharmaceutical Co Ltd:

  • The MRQ is 1.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.4%TTM2.0%-0.7%
TTM2.0%YOY2.3%-0.3%
TTM2.0%5Y2.3%-0.3%
5Y2.3%10Y2.4%-0.1%
1.1.3. Return on Equity

Shows how efficient China Resources Sanjiu Medical & Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare China Resources Sanjiu Medical & Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.8% Return on Equity means China Resources Sanjiu Medical & Pharmaceutical Co Ltd generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of China Resources Sanjiu Medical & Pharmaceutical Co Ltd:

  • The MRQ is 2.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 4.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.8%TTM4.0%-1.2%
TTM4.0%YOY3.5%+0.5%
TTM4.0%5Y3.7%+0.3%
5Y3.7%10Y3.8%-0.1%

1.2. Operating Efficiency of China Resources Sanjiu Medical & Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient China Resources Sanjiu Medical & Pharmaceutical Co Ltd is operating .

  • Measures how much profit China Resources Sanjiu Medical & Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare China Resources Sanjiu Medical & Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 15.0% means the company generated ¥0.15  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of China Resources Sanjiu Medical & Pharmaceutical Co Ltd:

  • The MRQ is 15.0%. The company is operating efficient. +1
  • The TTM is 15.5%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ15.0%TTM15.5%-0.5%
TTM15.5%YOY16.2%-0.7%
TTM15.5%5Y16.3%-0.8%
5Y16.3%10Y8.8%+7.5%
1.2.2. Operating Ratio

Measures how efficient China Resources Sanjiu Medical & Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.35 means that the operating costs are ¥1.35 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of China Resources Sanjiu Medical & Pharmaceutical Co Ltd:

  • The MRQ is 1.350. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.321. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.350TTM1.321+0.028
TTM1.321YOY1.262+0.059
TTM1.3215Y1.238+0.083
5Y1.23810Y0.838+0.400

1.3. Liquidity of China Resources Sanjiu Medical & Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if China Resources Sanjiu Medical & Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.77 means the company has ¥1.77 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of China Resources Sanjiu Medical & Pharmaceutical Co Ltd:

  • The MRQ is 1.769. The company is able to pay all its short-term debts. +1
  • The TTM is 1.589. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.769TTM1.589+0.180
TTM1.589YOY1.707-0.118
TTM1.5895Y1.610-0.021
5Y1.61010Y0.871+0.738
1.3.2. Quick Ratio

Measures if China Resources Sanjiu Medical & Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare China Resources Sanjiu Medical & Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.72 means the company can pay off ¥0.72 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of China Resources Sanjiu Medical & Pharmaceutical Co Ltd:

  • The MRQ is 0.722. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.661. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.722TTM0.661+0.061
TTM0.661YOY0.822-0.161
TTM0.6615Y0.745-0.084
5Y0.74510Y0.726+0.019

1.4. Solvency of China Resources Sanjiu Medical & Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of China Resources Sanjiu Medical & Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare China Resources Sanjiu Medical & Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.39 means that China Resources Sanjiu Medical & Pharmaceutical Co Ltd assets are financed with 38.9% credit (debt) and the remaining percentage (100% - 38.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of China Resources Sanjiu Medical & Pharmaceutical Co Ltd:

  • The MRQ is 0.389. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.385. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.389TTM0.385+0.004
TTM0.385YOY0.339+0.046
TTM0.3855Y0.346+0.040
5Y0.34610Y0.348-0.003
1.4.2. Debt to Equity Ratio

Measures if China Resources Sanjiu Medical & Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare China Resources Sanjiu Medical & Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 81.5% means that company has ¥0.81 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of China Resources Sanjiu Medical & Pharmaceutical Co Ltd:

  • The MRQ is 0.815. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.768. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.815TTM0.768+0.046
TTM0.768YOY0.528+0.240
TTM0.7685Y0.570+0.198
5Y0.57010Y0.563+0.007

2. Market Valuation of China Resources Sanjiu Medical & Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings China Resources Sanjiu Medical & Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare China Resources Sanjiu Medical & Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 23.56 means the investor is paying ¥23.56 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of China Resources Sanjiu Medical & Pharmaceutical Co Ltd:

  • The EOD is 24.790. Based on the earnings, the company is fair priced.
  • The MRQ is 23.563. Based on the earnings, the company is fair priced.
  • The TTM is 19.959. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD24.790MRQ23.563+1.227
MRQ23.563TTM19.959+3.605
TTM19.959YOY19.503+0.456
TTM19.9595Y27.066-7.107
5Y27.06610Y24.145+2.920
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of China Resources Sanjiu Medical & Pharmaceutical Co Ltd:

  • The EOD is 12.270. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 11.663. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 44.245. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD12.270MRQ11.663+0.607
MRQ11.663TTM44.245-32.582
TTM44.245YOY9.919+34.325
TTM44.2455Y28.715+15.530
5Y28.71510Y22.392+6.323
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of China Resources Sanjiu Medical & Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of China Resources Sanjiu Medical & Pharmaceutical Co Ltd:

  • The EOD is 2.205. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.096. Based on the equity, the company is underpriced. +1
  • The TTM is 2.449. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.205MRQ2.096+0.109
MRQ2.096TTM2.449-0.353
TTM2.449YOY2.459-0.009
TTM2.4495Y2.205+0.244
5Y2.20510Y2.626-0.421
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of China Resources Sanjiu Medical & Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.6641.707-61%0.377+76%0.647+3%0.444+49%
Book Value Per Share--23.90922.080+8%16.563+44%15.913+50%12.202+96%
Current Ratio--1.7691.589+11%1.707+4%1.610+10%0.871+103%
Debt To Asset Ratio--0.3890.385+1%0.339+15%0.346+13%0.348+12%
Debt To Equity Ratio--0.8150.768+6%0.528+54%0.570+43%0.563+45%
Dividend Per Share--0.0240.271-91%0.215-89%0.163-86%0.157-85%
Eps--0.5320.733-27%0.571-7%0.553-4%0.433+23%
Free Cash Flow Per Share--1.0740.776+38%0.398+170%0.444+142%0.510+111%
Free Cash Flow To Equity Per Share--0.5241.022-49%0.339+55%0.326+61%0.443+18%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--57.703--------
Intrinsic Value_10Y_min--22.884--------
Intrinsic Value_1Y_max--2.585--------
Intrinsic Value_1Y_min--2.069--------
Intrinsic Value_3Y_max--10.203--------
Intrinsic Value_3Y_min--6.448--------
Intrinsic Value_5Y_max--20.759--------
Intrinsic Value_5Y_min--11.046--------
Market Cap52106942320.000+5%49527782080.00053131451100.000-7%40272524065.000+23%35022887933.000+41%30099425850.500+65%
Net Profit Margin--0.0960.117-18%0.138-30%0.134-28%0.135-29%
Operating Margin--0.1500.155-3%0.162-7%0.163-7%0.088+71%
Operating Ratio--1.3501.321+2%1.262+7%1.238+9%0.838+61%
Pb Ratio2.205+5%2.0962.449-14%2.459-15%2.205-5%2.626-20%
Pe Ratio24.790+5%23.56319.959+18%19.503+21%27.066-13%24.145-2%
Price Per Share52.730+5%50.12053.760-7%40.753+23%35.440+41%30.459+65%
Price To Free Cash Flow Ratio12.270+5%11.66344.245-74%9.919+18%28.715-59%22.392-48%
Price To Total Gains Ratio76.679+5%72.88455.844+31%-0.782+101%97.382-25%83.682-13%
Quick Ratio--0.7220.661+9%0.822-12%0.745-3%0.726-1%
Return On Assets--0.0140.020-33%0.023-41%0.023-41%0.024-43%
Return On Equity--0.0280.040-30%0.035-19%0.037-24%0.038-25%
Total Gains Per Share--0.6881.978-65%0.592+16%0.811-15%0.602+14%
Usd Book Value--3269958680.3523020089035.663+8%2265304555.195+44%2176418845.134+50%1668877738.655+96%
Usd Book Value Change Per Share--0.0920.236-61%0.052+76%0.090+3%0.062+49%
Usd Book Value Per Share--3.3093.056+8%2.292+44%2.202+50%1.689+96%
Usd Dividend Per Share--0.0030.037-91%0.030-89%0.023-86%0.022-85%
Usd Eps--0.0740.101-27%0.079-7%0.077-4%0.060+23%
Usd Free Cash Flow--146931907.224106144035.999+38%54483407.386+170%60692661.118+142%69723768.480+111%
Usd Free Cash Flow Per Share--0.1490.107+38%0.055+170%0.061+142%0.071+111%
Usd Free Cash Flow To Equity Per Share--0.0730.141-49%0.047+55%0.045+61%0.061+18%
Usd Market Cap7211600817.088+5%6854645039.8727353392832.240-7%5573717330.596+23%4847167689.927+41%4165760537.709+65%
Usd Price Per Share7.298+5%6.9377.440-7%5.640+23%4.905+41%4.215+65%
Usd Profit--72725765.884100307673.790-27%78128598.872-7%75620911.050-4%59273137.206+23%
Usd Revenue--755924227.857850355441.384-11%565067768.120+34%583564200.013+30%454147773.516+66%
Usd Total Gains Per Share--0.0950.274-65%0.082+16%0.112-15%0.083+14%
 EOD+4 -4MRQTTM+12 -23YOY+19 -165Y+18 -1710Y+24 -11

3.2. Fundamental Score

Let's check the fundamental score of China Resources Sanjiu Medical & Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1524.790
Price to Book Ratio (EOD)Between0-12.205
Net Profit Margin (MRQ)Greater than00.096
Operating Margin (MRQ)Greater than00.150
Quick Ratio (MRQ)Greater than10.722
Current Ratio (MRQ)Greater than11.769
Debt to Asset Ratio (MRQ)Less than10.389
Debt to Equity Ratio (MRQ)Less than10.815
Return on Equity (MRQ)Greater than0.150.028
Return on Assets (MRQ)Greater than0.050.014
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of China Resources Sanjiu Medical & Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.606
Ma 20Greater thanMa 5053.842
Ma 50Greater thanMa 10053.710
Ma 100Greater thanMa 20050.753
OpenGreater thanClose52.760
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets38,698,061
Total Liabilities15,071,192
Total Stockholder Equity18,501,077
 As reported
Total Liabilities 15,071,192
Total Stockholder Equity+ 18,501,077
Total Assets = 38,698,061

Assets

Total Assets38,698,061
Total Current Assets21,053,258
Long-term Assets17,644,802
Total Current Assets
Cash And Cash Equivalents 6,614,143
Short-term Investments 681,398
Net Receivables 7,903,725
Inventory 4,890,448
Other Current Assets 963,545
Total Current Assets  (as reported)21,053,258
Total Current Assets  (calculated)21,053,258
+/- 0
Long-term Assets
Property Plant Equipment 6,556,281
Goodwill 5,181,295
Intangible Assets 4,119,353
Other Assets 1,810,878
Long-term Assets  (as reported)17,644,802
Long-term Assets  (calculated)17,667,807
+/- 23,005

Liabilities & Shareholders' Equity

Total Current Liabilities11,898,654
Long-term Liabilities3,172,538
Total Stockholder Equity18,501,077
Total Current Liabilities
Short Long Term Debt 838,563
Accounts payable 2,977,716
Other Current Liabilities 6,867,574
Total Current Liabilities  (as reported)11,898,654
Total Current Liabilities  (calculated)10,683,853
+/- 1,214,801
Long-term Liabilities
Long term Debt 1,773,399
Capital Lease Obligations Min Short Term Debt135,667
Other Liabilities 1,263,471
Long-term Liabilities Other 88,760
Deferred Long Term Liability 829,046
Long-term Liabilities  (as reported)3,172,538
Long-term Liabilities  (calculated)4,090,343
+/- 917,805
Total Stockholder Equity
Common Stock988,184
Retained Earnings 15,711,596
Other Stockholders Equity 75,981
Total Stockholder Equity (as reported)18,501,077
Total Stockholder Equity (calculated)16,775,762
+/- 1,725,315
Other
Capital Stock988,184
Common Stock Shares Outstanding 988,184
Net Invested Capital 21,113,040
Net Tangible Assets 9,860,154
Net Working Capital 9,154,605
Property Plant and Equipment Gross 6,556,281



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-30
> Total Assets 
4,869,721
5,889,852
6,049,091
6,599,074
6,683,810
8,196,734
8,218,115
6,850,211
7,324,073
7,674,906
7,976,009
8,296,246
8,227,974
8,236,668
7,858,558
7,177,607
7,063,788
6,994,743
6,978,909
7,043,277
6,885,954
6,901,273
6,985,452
7,054,590
7,394,491
7,625,642
7,794,582
7,773,389
7,810,050
4,595,068
4,846,183
5,051,458
5,366,943
5,154,240
5,544,125
5,631,417
5,591,292
5,431,428
5,817,227
6,091,160
6,289,541
6,189,183
6,380,648
7,599,036
7,638,347
7,709,974
7,777,907
8,612,413
8,928,900
9,432,372
9,447,372
10,242,491
10,287,703
10,478,741
10,512,368
10,667,242
10,924,506
11,085,093
11,313,766
12,019,259
12,043,989
12,372,183
14,427,669
13,551,748
13,942,027
14,352,512
15,159,203
16,195,464
16,572,895
16,276,079
16,677,963
18,029,932
17,896,129
18,482,654
18,313,996
20,103,526
20,150,647
20,112,442
20,525,256
22,010,147
22,252,319
22,672,059
22,622,287
24,307,981
24,148,153
25,299,355
25,306,522
27,122,782
37,879,854
38,865,563
38,698,061
38,698,06138,865,56337,879,85427,122,78225,306,52225,299,35524,148,15324,307,98122,622,28722,672,05922,252,31922,010,14720,525,25620,112,44220,150,64720,103,52618,313,99618,482,65417,896,12918,029,93216,677,96316,276,07916,572,89516,195,46415,159,20314,352,51213,942,02713,551,74814,427,66912,372,18312,043,98912,019,25911,313,76611,085,09310,924,50610,667,24210,512,36810,478,74110,287,70310,242,4919,447,3729,432,3728,928,9008,612,4137,777,9077,709,9747,638,3477,599,0366,380,6486,189,1836,289,5416,091,1605,817,2275,431,4285,591,2925,631,4175,544,1255,154,2405,366,9435,051,4584,846,1834,595,0687,810,0507,773,3897,794,5827,625,6427,394,4917,054,5906,985,4526,901,2736,885,9547,043,2776,978,9096,994,7437,063,7887,177,6077,858,5588,236,6688,227,9748,296,2467,976,0097,674,9067,324,0736,850,2118,218,1158,196,7346,683,8106,599,0746,049,0915,889,8524,869,721
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,804,853
7,105,804
8,576,492
8,425,052
9,019,589
8,780,798
10,292,798
9,302,288
9,045,638
9,490,528
10,925,249
10,825,179
11,206,885
10,946,985
12,478,397
12,294,627
13,324,939
13,174,708
11,988,490
20,405,579
21,179,386
21,053,258
21,053,25821,179,38620,405,57911,988,49013,174,70813,324,93912,294,62712,478,39710,946,98511,206,88510,825,17910,925,2499,490,5289,045,6389,302,28810,292,7988,780,7989,019,5898,425,0528,576,4927,105,8046,804,853000000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,559,490
1,551,105
2,476,366
1,246,035
1,660,669
1,837,366
3,045,800
1,711,479
2,673,934
2,904,401
3,822,205
2,941,788
3,446,175
2,744,649
3,065,099
3,439,746
4,575,990
3,888,397
3,149,709
5,330,116
6,699,616
6,614,143
6,614,1436,699,6165,330,1163,149,7093,888,3974,575,9903,439,7463,065,0992,744,6493,446,1752,941,7883,822,2052,904,4012,673,9341,711,4793,045,8001,837,3661,660,6691,246,0352,476,3661,551,1051,559,490000000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
900,000
995,000
825,000
0
1,700,000
990,000
745,000
200,180
939,000
1,082,725
1,364,465
1,218,781
1,171,474
1,569,920
1,565,612
0
0
80,000
681,398
681,39880,000001,565,6121,569,9201,171,4741,218,7811,364,4651,082,725939,000200,180745,000990,0001,700,0000825,000995,000900,000000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
1,567,494
1,860,190
1,792,020
3,246,744
3,342,573
3,437,795
3,316,475
2,671,777
2,814,122
2,916,570
3,064,086
3,537,476
3,391,052
4,183,856
3,974,589
4,542,991
4,454,436
4,592,077
4,567,501
4,752,464
4,395,187
4,552,470
4,517,856
4,646,298
4,524,795
4,658,194
4,661,439
5,025,166
4,944,493
1,037,559
1,143,651
1,344,407
1,157,421
1,131,094
1,181,616
1,267,754
1,194,096
976,484
1,065,066
1,167,716
1,266,410
1,128,092
1,204,827
1,370,503
1,712,398
1,521,539
1,400,345
1,768,792
1,953,980
1,778,722
1,819,314
2,050,236
2,020,236
1,926,346
1,819,673
1,932,369
2,162,137
1,777,772
1,952,640
2,390,218
2,346,752
2,193,195
2,424,246
2,784,971
2,899,100
2,665,601
2,879,832
3,878,289
4,156,205
3,331,184
3,263,591
4,187,256
2,241,567
2,391,557
2,356,107
5,580,678
4,006,856
3,281,710
3,806,383
4,875,898
4,841,814
4,279,250
4,109,391
5,376,923
4,871,190
4,363,566
4,517,665
4,087,324
9,886,211
8,866,664
7,903,725
7,903,7258,866,6649,886,2114,087,3244,517,6654,363,5664,871,1905,376,9234,109,3914,279,2504,841,8144,875,8983,806,3833,281,7104,006,8565,580,6782,356,1072,391,5572,241,5674,187,2563,263,5913,331,1844,156,2053,878,2892,879,8322,665,6012,899,1002,784,9712,424,2462,193,1952,346,7522,390,2181,952,6401,777,7722,162,1371,932,3691,819,6731,926,3462,020,2362,050,2361,819,3141,778,7221,953,9801,768,7921,400,3451,521,5391,712,3981,370,5031,204,8271,128,0921,266,4101,167,7161,065,066976,4841,194,0961,267,7541,181,6161,131,0941,157,4211,344,4071,143,6511,037,5594,944,4935,025,1664,661,4394,658,1944,524,7954,646,2984,517,8564,552,4704,395,1874,752,4644,567,5014,592,0774,454,4364,542,9913,974,5894,183,8563,391,0523,537,4763,064,0862,916,5702,814,1222,671,7773,316,4753,437,7953,342,5733,246,7441,792,0201,860,1901,567,494
       Other Current Assets 
124,285
128,861
149,828
574,326
585,647
166,288
143,512
232,061
191,708
177,618
185,358
269,305
278,882
303,983
332,204
65,896
75,997
71,660
79,329
25,282
261,824
39,244
78,699
96,676
113,254
104,461
88,677
47,020
55,116
62,325
53,670
39,752
49,490
64,574
75,692
77,841
83,500
115,973
159,166
115,668
89,214
128,234
214,854
69,711
108,063
115,059
191,866
199,454
218,364
245,650
718,708
763,381
757,555
194,209
952,232
92,632
1,213,601
100,179
859,708
89,373
1,253,085
96,049
768,585
81,870
324,698
98,013
700,563
151,813
947,836
158,223
412,632
379,451
347,755
481,480
327,389
233,882
345,643
324,165
300,660
265,370
375,667
385,302
479,290
508,211
525,859
436,307
567,739
268,633
852,235
935,165
963,545
963,545935,165852,235268,633567,739436,307525,859508,211479,290385,302375,667265,370300,660324,165345,643233,882327,389481,480347,755379,451412,632158,223947,836151,813700,56398,013324,69881,870768,58596,0491,253,08589,373859,708100,1791,213,60192,632952,232194,209757,555763,381718,708245,650218,364199,454191,866115,059108,06369,711214,854128,23489,214115,668159,166115,97383,50077,84175,69264,57449,49039,75253,67062,32555,11647,02088,677104,461113,25496,67678,69939,244261,82425,28279,32971,66075,99765,896332,204303,983278,882269,305185,358177,618191,708232,061143,512166,288585,647574,326149,828128,861124,285
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,471,077
9,463,064
9,533,199
9,810,727
10,848,359
11,066,804
11,034,727
11,084,899
11,427,140
11,465,174
11,675,303
11,829,584
11,853,527
11,974,416
12,131,814
15,134,292
17,474,275
17,686,176
17,644,802
17,644,80217,686,17617,474,27515,134,29212,131,81411,974,41611,853,52711,829,58411,675,30311,465,17411,427,14011,084,89911,034,72711,066,80410,848,3599,810,7279,533,1999,463,0649,471,077000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
694,757
799,328
769,509
776,214
769,936
1,308,450
1,351,691
913,445
937,438
973,265
954,919
1,028,441
1,061,237
1,098,688
1,098,831
1,070,926
1,067,909
1,113,404
1,039,361
1,053,150
0
1,036,027
990,133
1,038,121
1,033,824
1,076,872
1,067,732
1,141,436
1,082,191
1,234,340
1,230,973
1,328,710
1,257,224
1,358,136
1,383,533
1,435,171
1,311,252
1,419,501
1,351,764
1,431,135
1,415,348
1,567,036
1,533,115
2,196,752
2,132,551
2,421,922
2,223,763
2,695,047
2,559,982
2,904,917
2,630,759
3,093,291
2,757,514
2,745,228
2,811,732
2,808,832
2,769,251
2,836,927
2,953,806
3,076,732
3,068,729
3,095,591
3,165,278
3,272,319
3,290,483
3,403,135
3,494,797
3,555,296
3,525,240
3,566,725
3,619,027
3,525,970
3,519,451
3,526,765
3,550,368
3,609,847
3,641,409
3,698,892
3,698,251
3,767,237
4,053,737
4,070,122
4,103,351
4,234,499
4,240,390
4,329,473
4,479,412
4,823,004
6,426,619
6,568,761
6,556,281
6,556,2816,568,7616,426,6194,823,0044,479,4124,329,4734,240,3904,234,4994,103,3514,070,1224,053,7373,767,2373,698,2513,698,8923,641,4093,609,8473,550,3683,526,7653,519,4513,525,9703,619,0273,566,7253,525,2403,555,2963,494,7973,403,1353,290,4833,272,3193,165,2783,095,5913,068,7293,076,7322,953,8062,836,9272,769,2512,808,8322,811,7322,745,2282,757,5143,093,2912,630,7592,904,9172,559,9822,695,0472,223,7632,421,9222,132,5512,196,7521,533,1151,567,0361,415,3481,431,1351,351,7641,419,5011,311,2521,435,1711,383,5331,358,1361,257,2241,328,7101,230,9731,234,3401,082,1911,141,4361,067,7321,076,8721,033,8241,038,121990,1331,036,02701,053,1501,039,3611,113,4041,067,9091,070,9261,098,8311,098,6881,061,2371,028,441954,919973,265937,438913,4451,351,6911,308,450769,936776,214769,509799,328694,757
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
581,892
581,892
667,397
707,319
707,319
707,319
1,744,937
1,730,696
1,730,696
1,730,696
3,153,477
3,142,163
3,296,013
3,306,803
3,558,227
3,549,848
3,549,848
3,549,848
3,549,848
3,543,949
3,543,949
3,543,949
3,543,949
3,353,682
4,279,518
4,279,518
4,279,518
4,104,569
4,104,595
4,104,595
4,104,595
4,060,359
4,060,359
4,060,359
4,060,359
3,994,851
5,197,198
5,181,295
5,181,295
5,181,2955,181,2955,197,1983,994,8514,060,3594,060,3594,060,3594,060,3594,104,5954,104,5954,104,5954,104,5694,279,5184,279,5184,279,5183,353,6823,543,9493,543,9493,543,9493,543,9493,549,8483,549,8483,549,8483,549,8483,558,2273,306,8033,296,0133,142,1633,153,4771,730,6961,730,6961,730,6961,744,937707,319707,319707,319667,397581,892581,8920000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,176
14,927
47,543
47,452
50,074
44,180
41,825
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000041,82544,18050,07447,45247,54314,9275,176000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
103,019
98,704
82,201
74,399
77,057
94,759
110,589
83,280
89,472
86,997
77,498
81,329
86,709
83,648
83,615
51,954
55,542
10,863
52,624
4,173
0
2,787
44,579
12,874
54,003
11,494
55,635
12,976
74,124
1,027,679
1,108,003
1,022,810
1,106,749
1,021,826
1,119,175
1,041,939
1,147,746
1,039,875
1,169,223
1,037,415
1,160,324
1,035,629
1,161,546
1,056,273
1,752,916
1,214,229
1,770,724
1,153,747
2,105,559
1,182,095
2,134,904
1,182,089
2,127,437
2,119,153
2,227,440
2,285,924
2,290,133
2,284,971
3,467,637
3,461,601
3,454,476
3,449,762
4,975,254
4,953,435
5,174,127
5,184,721
5,474,207
5,460,376
5,440,940
1,879,980
1,867,780
1,843,352
2,038,459
1,557,753
2,061,885
2,097,395
2,472,261
2,545,265
2,536,063
2,586,921
2,615,067
2,593,104
2,633,900
2,646,596
2,640,028
2,642,555
2,657,788
2,749,899
4,090,728
4,099,890
4,119,353
4,119,3534,099,8904,090,7282,749,8992,657,7882,642,5552,640,0282,646,5962,633,9002,593,1042,615,0672,586,9212,536,0632,545,2652,472,2612,097,3952,061,8851,557,7532,038,4591,843,3521,867,7801,879,9805,440,9405,460,3765,474,2075,184,7215,174,1274,953,4354,975,2543,449,7623,454,4763,461,6013,467,6372,284,9712,290,1332,285,9242,227,4402,119,1532,127,4371,182,0892,134,9041,182,0952,105,5591,153,7471,770,7241,214,2291,752,9161,056,2731,161,5461,035,6291,160,3241,037,4151,169,2231,039,8751,147,7461,041,9391,119,1751,021,8261,106,7491,022,8101,108,0031,027,67974,12412,97655,63511,49454,00312,87444,5792,78704,17352,62410,86355,54251,95483,61583,64886,70981,32977,49886,99789,47283,280110,58994,75977,05774,39982,20198,704103,019
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
127,257
132,281
134,020
473,417
145,370
176,503
3,872,580
166,736
205,062
230,819
282,856
264,074
301,514
308,017
300,173
2,776,896
331,421
326,495
288,197
288,197326,495331,4212,776,896300,173308,017301,514264,074282,856230,819205,062166,7363,872,580176,503145,370473,417134,020132,281127,257000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
1,963,100
2,909,634
2,993,179
3,646,888
3,680,010
4,652,162
4,630,660
3,948,252
4,362,985
4,661,889
4,933,550
5,202,414
5,096,766
5,036,611
4,709,906
4,889,762
4,719,163
4,653,573
4,615,738
4,650,950
4,456,591
4,437,572
4,508,093
4,509,430
4,691,689
4,929,984
5,033,199
4,889,941
4,843,286
1,505,885
1,590,141
1,638,776
1,774,740
1,604,599
1,745,392
1,679,947
1,438,195
1,405,561
1,575,481
1,627,394
1,591,186
1,588,227
1,592,444
2,748,476
2,462,307
2,567,214
2,392,325
3,036,329
3,126,757
3,616,450
3,388,410
3,881,460
3,584,438
3,485,340
3,590,642
3,671,721
3,581,748
3,444,047
3,863,086
4,345,119
4,055,108
4,197,889
6,032,116
4,830,393
4,818,571
4,871,239
5,388,633
6,070,782
5,992,836
5,726,712
5,847,809
6,861,435
5,592,141
5,995,235
5,586,868
7,221,648
6,730,967
6,584,270
6,500,428
7,951,103
7,482,401
7,678,262
7,232,281
8,595,266
7,589,968
8,980,853
8,424,693
9,589,367
14,728,791
15,891,099
15,071,192
15,071,19215,891,09914,728,7919,589,3678,424,6938,980,8537,589,9688,595,2667,232,2817,678,2627,482,4017,951,1036,500,4286,584,2706,730,9677,221,6485,586,8685,995,2355,592,1416,861,4355,847,8095,726,7125,992,8366,070,7825,388,6334,871,2394,818,5714,830,3936,032,1164,197,8894,055,1084,345,1193,863,0863,444,0473,581,7483,671,7213,590,6423,485,3403,584,4383,881,4603,388,4103,616,4503,126,7573,036,3292,392,3252,567,2142,462,3072,748,4761,592,4441,588,2271,591,1861,627,3941,575,4811,405,5611,438,1951,679,9471,745,3921,604,5991,774,7401,638,7761,590,1411,505,8854,843,2864,889,9415,033,1994,929,9844,691,6894,509,4304,508,0934,437,5724,456,5914,650,9504,615,7384,653,5734,719,1634,889,7624,709,9065,036,6115,096,7665,202,4144,933,5504,661,8894,362,9853,948,2524,630,6604,652,1623,680,0103,646,8882,993,1792,909,6341,963,100
   > Total Current Liabilities 
1,757,714
2,738,352
2,768,532
3,453,219
3,549,617
4,532,672
4,519,652
3,920,133
4,322,498
4,567,206
4,842,329
5,116,941
4,976,925
4,929,419
4,582,247
4,821,664
4,645,875
4,580,893
4,543,831
4,587,974
4,398,216
4,377,347
4,448,338
4,464,013
4,646,272
4,909,391
5,012,241
4,874,354
4,827,699
1,498,191
1,573,677
1,624,147
1,737,256
1,566,560
1,707,988
1,613,060
1,381,462
1,347,150
1,520,586
1,572,722
1,536,375
1,525,219
1,528,902
2,635,652
2,289,891
2,369,107
2,061,516
2,700,578
2,761,654
2,759,025
2,527,821
3,026,809
2,699,078
2,579,727
2,641,400
2,671,086
2,560,855
2,425,798
2,824,238
3,301,425
2,999,945
3,167,337
4,982,702
3,787,026
3,773,864
3,816,173
4,323,037
5,504,486
5,428,326
5,168,259
5,290,511
6,316,555
5,053,850
5,455,402
5,054,339
6,693,188
6,154,384
6,014,925
5,918,134
7,295,475
6,689,979
6,895,331
6,448,351
7,775,436
6,742,488
8,116,654
7,488,911
8,672,699
13,201,542
12,765,609
11,898,654
11,898,65412,765,60913,201,5428,672,6997,488,9118,116,6546,742,4887,775,4366,448,3516,895,3316,689,9797,295,4755,918,1346,014,9256,154,3846,693,1885,054,3395,455,4025,053,8506,316,5555,290,5115,168,2595,428,3265,504,4864,323,0373,816,1733,773,8643,787,0264,982,7023,167,3372,999,9453,301,4252,824,2382,425,7982,560,8552,671,0862,641,4002,579,7272,699,0783,026,8092,527,8212,759,0252,761,6542,700,5782,061,5162,369,1072,289,8912,635,6521,528,9021,525,2191,536,3751,572,7221,520,5861,347,1501,381,4621,613,0601,707,9881,566,5601,737,2561,624,1471,573,6771,498,1914,827,6994,874,3545,012,2414,909,3914,646,2724,464,0134,448,3384,377,3474,398,2164,587,9744,543,8314,580,8934,645,8754,821,6644,582,2474,929,4194,976,9255,116,9414,842,3294,567,2064,322,4983,920,1334,519,6524,532,6723,549,6173,453,2192,768,5322,738,3521,757,714
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
225
225
225
35,000
25,000
25,000
30,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000030,00025,00025,00035,000225225225000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
225
225
225
35,000
25,000
25,000
30,000
99,509
174,968
179,968
25,000
25,000
40,000
65,000
60,000
65,000
201,879
466,424
168,500
1,434,058
1,026,514
838,563
838,5631,026,5141,434,058168,500466,424201,87965,00060,00065,00040,00025,00025,000179,968174,96899,50930,00025,00025,00035,000225225225000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
350,225
460,090
520,943
331,140
426,438
498,138
769,418
790,200
1,013,730
1,056,042
1,216,787
684,357
620,858
741,265
669,665
831,549
730,351
665,177
616,674
540,192
450,600
472,174
492,025
468,169
514,585
485,026
499,007
490,887
486,049
502,165
503,779
713,593
696,521
689,250
778,635
629,739
462,028
466,183
483,079
606,015
532,425
614,189
602,315
804,469
723,420
756,782
679,094
721,291
747,384
733,466
727,237
1,033,717
906,067
787,018
809,751
725,652
772,276
783,054
808,272
924,547
835,956
798,338
820,257
903,636
980,858
1,014,924
975,080
1,132,148
1,118,803
1,125,170
1,005,863
1,041,223
902,684
986,306
968,885
1,027,314
984,223
974,041
928,387
1,117,591
1,234,066
1,383,861
1,327,751
1,415,811
1,549,956
1,786,407
1,942,971
1,795,121
3,121,540
2,959,696
2,977,716
2,977,7162,959,6963,121,5401,795,1211,942,9711,786,4071,549,9561,415,8111,327,7511,383,8611,234,0661,117,591928,387974,041984,2231,027,314968,885986,306902,6841,041,2231,005,8631,125,1701,118,8031,132,148975,0801,014,924980,858903,636820,257798,338835,956924,547808,272783,054772,276725,652809,751787,018906,0671,033,717727,237733,466747,384721,291679,094756,782723,420804,469602,315614,189532,425606,015483,079466,183462,028629,739778,635689,250696,521713,593503,779502,165486,049490,887499,007485,026514,585468,169492,025472,174450,600540,192616,674665,177730,351831,549669,665741,265620,858684,3571,216,7871,056,0421,013,730790,200769,418498,138426,438331,140520,943460,090350,225
       Other Current Liabilities 
256,719
453,462
385,029
382,759
383,009
398,694
316,830
397,223
500,332
319,354
328,132
399,824
330,007
487,204
364,680
601,232
542,741
674,180
715,847
802,963
3,947,616
664,051
718,541
762,799
896,763
1,196,668
1,284,565
1,279,890
1,233,573
950,826
1,014,698
815,104
770,194
782,601
887,153
971,321
907,434
850,967
1,007,507
923,707
960,950
887,930
926,587
1,769,926
1,525,002
1,550,645
1,303,536
1,900,194
1,884,975
1,986,060
1,777,978
1,956,140
1,756,059
1,769,807
1,808,897
1,908,497
1,765,643
1,629,708
2,002,929
2,376,161
2,163,273
2,368,773
4,162,220
2,863,284
2,732,899
2,738,679
3,290,453
3,842,269
3,769,343
1,328,909
3,727,270
1,863,308
394,274
289,369
18,289
2,110,977
4,510,822
2,294,589
4,163,458
2,606,181
4,816,457
2,596,300
4,311,921
2,877,141
4,369,208
3,077,769
4,237,087
363,945
7,479,318
4,021,032
6,867,574
6,867,5744,021,0327,479,318363,9454,237,0873,077,7694,369,2082,877,1414,311,9212,596,3004,816,4572,606,1814,163,4582,294,5894,510,8222,110,97718,289289,369394,2741,863,3083,727,2701,328,9093,769,3433,842,2693,290,4532,738,6792,732,8992,863,2844,162,2202,368,7732,163,2732,376,1612,002,9291,629,7081,765,6431,908,4971,808,8971,769,8071,756,0591,956,1401,777,9781,986,0601,884,9751,900,1941,303,5361,550,6451,525,0021,769,926926,587887,930960,950923,7071,007,507850,967907,434971,321887,153782,601770,194815,1041,014,698950,8261,233,5731,279,8901,284,5651,196,668896,763762,799718,541664,0513,947,616802,963715,847674,180542,741601,232364,680487,204330,007399,824328,132319,354500,332397,223316,830398,694383,009382,759385,029453,462256,719
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
538,292
539,833
532,529
528,460
576,582
569,345
582,294
655,628
792,422
782,931
783,930
819,830
847,480
864,199
935,782
916,668
1,527,249
3,125,490
3,172,538
3,172,5383,125,4901,527,249916,668935,782864,199847,480819,830783,930782,931792,422655,628582,294569,345576,582528,460532,529539,833538,292000000000000000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-225
-225
-225
-35,000
-25,000
-25,000
-30,000
0
0
0
0
135,471
89,904
85,464
88,708
91,879
89,898
80,656
105,822
141,872
139,023
135,667
135,667139,023141,872105,82280,65689,89891,87988,70885,46489,904135,4710000-30,000-25,000-25,000-35,000-225-225-225000000000000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,559
1,559
1,559
1,559
1,559
1,559
1,559
1,559
1,559
1,559
1,559
12,750
12,749
56
70,126
56
85,717
87,175
88,760
88,76087,17585,7175670,1265612,74912,7501,5591,5591,5591,5591,5591,5591,5591,5591,5591,5591,559000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
238,205
252,066
269,008
288,158
282,723
326,174
380,955
405,033
420,664
433,901
522,683
541,533
517,392
438,902
466,286
468,832
479,275
403,921
0
729,907
789,491
829,046
829,046789,491729,9070403,921479,275468,832466,286438,902517,392541,533522,683433,901420,664405,033380,955326,174282,723288,158269,008252,066238,205000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
2,695,186
2,582,483
2,653,441
2,603,895
2,619,767
2,689,508
2,719,167
2,698,881
2,719,110
2,795,442
2,836,631
2,909,307
2,926,038
3,004,927
2,946,571
2,113,879
2,164,066
2,174,661
2,196,840
2,232,693
2,429,362
2,314,020
2,330,335
2,396,848
2,548,790
2,539,912
2,602,472
2,729,814
2,809,423
2,895,097
3,055,446
3,200,048
3,366,362
3,314,767
3,487,044
3,686,286
3,924,415
3,792,861
3,995,912
4,212,917
4,430,864
4,315,755
4,490,976
4,544,990
4,851,832
4,825,130
5,050,488
5,309,766
5,607,529
5,611,725
5,842,561
6,148,823
6,479,473
6,765,973
6,683,326
6,759,945
7,098,923
7,387,003
7,189,000
7,571,681
7,884,056
8,064,617
8,290,226
8,615,021
8,989,706
9,279,236
9,496,980
9,838,512
10,262,236
10,220,152
10,504,648
10,827,719
11,994,431
12,168,293
12,420,815
12,563,844
13,097,296
13,203,021
13,706,113
13,727,095
14,362,749
14,596,179
14,980,564
15,282,502
16,121,152
15,863,421
16,425,795
17,009,633
18,177,578
17,956,368
18,501,077
18,501,07717,956,36818,177,57817,009,63316,425,79515,863,42116,121,15215,282,50214,980,56414,596,17914,362,74913,727,09513,706,11313,203,02113,097,29612,563,84412,420,81512,168,29311,994,43110,827,71910,504,64810,220,15210,262,2369,838,5129,496,9809,279,2368,989,7068,615,0218,290,2268,064,6177,884,0567,571,6817,189,0007,387,0037,098,9236,759,9456,683,3266,765,9736,479,4736,148,8235,842,5615,611,7255,607,5295,309,7665,050,4884,825,1304,851,8324,544,9904,490,9764,315,7554,430,8644,212,9173,995,9123,792,8613,924,4153,686,2863,487,0443,314,7673,366,3623,200,0483,055,4462,895,0972,809,4232,729,8142,602,4722,539,9122,548,7902,396,8482,330,3352,314,0202,429,3622,232,6932,196,8402,174,6612,164,0662,113,8792,946,5713,004,9272,926,0382,909,3072,836,6312,795,4422,719,1102,698,8812,719,1672,689,5082,619,7672,603,8952,653,4412,582,4832,695,186
   Common Stock
753,000
753,000
753,000
753,000
753,000
753,000
753,000
753,000
753,000
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
978,900
987,140
988,346
0
988,346
988,346
988,184
988,184988,346988,3460988,346987,140978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900978,900753,000753,000753,000753,000753,000753,000753,000753,000753,000
   Retained Earnings 
228,244
56,729
127,686
76,698
92,570
162,311
198,783
146,311
166,540
242,873
279,369
322,792
339,524
413,211
355,365
0
0
0
0
0
0
0
0
0
0
0
3,789
250,976
329,703
416,064
576,186
694,904
861,160
805,087
977,373
1,149,283
1,387,372
1,241,908
1,444,802
1,625,954
1,843,955
1,728,931
1,903,083
2,063,292
2,370,143
2,343,979
2,569,022
2,776,412
3,114,586
3,118,945
3,391,508
3,599,495
4,357,753
4,644,263
4,561,838
4,644,410
4,983,414
5,271,501
5,073,498
5,494,245
5,806,612
5,983,550
6,216,708
6,545,251
6,919,944
7,129,882
7,347,742
7,690,314
8,113,229
8,071,435
8,355,497
8,677,011
9,307,948
9,481,661
9,728,727
10,407,735
10,941,045
11,047,633
11,551,010
11,117,386
11,752,892
11,985,683
12,361,643
12,667,359
13,506,073
13,270,225
13,789,494
13,761,435
15,448,373
15,186,121
15,711,596
15,711,59615,186,12115,448,37313,761,43513,789,49413,270,22513,506,07312,667,35912,361,64311,985,68311,752,89211,117,38611,551,01011,047,63310,941,04510,407,7359,728,7279,481,6619,307,9488,677,0118,355,4978,071,4358,113,2297,690,3147,347,7427,129,8826,919,9446,545,2516,216,7085,983,5505,806,6125,494,2455,073,4985,271,5014,983,4144,644,4104,561,8384,644,2634,357,7533,599,4953,391,5083,118,9453,114,5862,776,4122,569,0222,343,9792,370,1432,063,2921,903,0831,728,9311,843,9551,625,9541,444,8021,241,9081,387,3721,149,283977,373805,087861,160694,904576,186416,064329,703250,9763,78900000000000355,365413,211339,524322,792279,369242,873166,540146,311198,783162,31192,57076,698127,68656,729228,244
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-10,941
-10,658
-8,951
-9,083
-8,933
-3,478
-3,549
-3,407
-4,270
-4,556
-4,962
-4,923
-4,283
3,994
216
152
616
36,693
0
66,467
77,374
75,981
75,98177,37466,467036,6936161522163,994-4,283-4,923-4,962-4,556-4,270-3,407-3,549-3,478-8,933-9,083-8,951-10,658-10,941000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue24,576,747
Cost of Revenue-11,806,738
Gross Profit12,770,00912,770,009
 
Operating Income (+$)
Gross Profit12,770,009
Operating Expense-20,629,414
Operating Income3,947,333-7,859,405
 
Operating Expense (+$)
Research Development699,595
Selling General Administrative7,273,646
Selling And Marketing Expenses-
Operating Expense20,629,4147,973,241
 
Net Interest Income (+$)
Interest Income51,125
Interest Expense-59,241
Other Finance Cost-68,691
Net Interest Income60,576
 
Pretax Income (+$)
Operating Income3,947,333
Net Interest Income60,576
Other Non-Operating Income Expenses-
Income Before Tax (EBT)3,785,5043,947,333
EBIT - interestExpense = -59,241
2,899,066
2,958,307
Interest Expense59,241
Earnings Before Interest and Taxes (EBIT)-3,844,745
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax3,785,504
Tax Provision-571,502
Net Income From Continuing Ops3,214,0023,214,002
Net Income2,899,066
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--60,576
 

Technical Analysis of China Resources Sanjiu Medical & Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of China Resources Sanjiu Medical & Pharmaceutical Co Ltd. The general trend of China Resources Sanjiu Medical & Pharmaceutical Co Ltd is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine China Resources Sanjiu Medical & Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of China Resources Sanjiu Medical & Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 56.47 < 57.50 < 59.00.

The bearish price targets are: 51.33 > 48.12 > 47.35.

Tweet this
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of China Resources Sanjiu Medical & Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

China Resources Sanjiu Medical & Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of China Resources Sanjiu Medical & Pharmaceutical Co Ltd. The current macd is -0.32293639.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the China Resources Sanjiu Medical & Pharmaceutical Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for China Resources Sanjiu Medical & Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the China Resources Sanjiu Medical & Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartChina Resources Sanjiu Medical & Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of China Resources Sanjiu Medical & Pharmaceutical Co Ltd. The current adx is 13.78.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell China Resources Sanjiu Medical & Pharmaceutical Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of China Resources Sanjiu Medical & Pharmaceutical Co Ltd. The current sar is 54.60.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of China Resources Sanjiu Medical & Pharmaceutical Co Ltd. The current rsi is 45.61. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartChina Resources Sanjiu Medical & Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of China Resources Sanjiu Medical & Pharmaceutical Co Ltd. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the China Resources Sanjiu Medical & Pharmaceutical Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartChina Resources Sanjiu Medical & Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of China Resources Sanjiu Medical & Pharmaceutical Co Ltd. The current cci is -82.70777586.

China Resources Sanjiu Medical & Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartChina Resources Sanjiu Medical & Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of China Resources Sanjiu Medical & Pharmaceutical Co Ltd. The current cmo is -12.97697193.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartChina Resources Sanjiu Medical & Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of China Resources Sanjiu Medical & Pharmaceutical Co Ltd. The current willr is -73.30415755.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that China Resources Sanjiu Medical & Pharmaceutical Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Daily Williams %R ChartChina Resources Sanjiu Medical & Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of China Resources Sanjiu Medical & Pharmaceutical Co Ltd.

China Resources Sanjiu Medical & Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of China Resources Sanjiu Medical & Pharmaceutical Co Ltd. The current atr is 1.65502667.

China Resources Sanjiu Medical & Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartChina Resources Sanjiu Medical & Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of China Resources Sanjiu Medical & Pharmaceutical Co Ltd. The current obv is -4,047,654.

China Resources Sanjiu Medical & Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartChina Resources Sanjiu Medical & Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of China Resources Sanjiu Medical & Pharmaceutical Co Ltd. The current mfi is 52.15.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartChina Resources Sanjiu Medical & Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for China Resources Sanjiu Medical & Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-24ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-30MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-25STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

China Resources Sanjiu Medical & Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of China Resources Sanjiu Medical & Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.606
Ma 20Greater thanMa 5053.842
Ma 50Greater thanMa 10053.710
Ma 100Greater thanMa 20050.753
OpenGreater thanClose52.760
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of China Resources Sanjiu Medical & Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on China Resources Sanjiu Medical & Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about China Resources Sanjiu Medical & Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about China Resources Sanjiu Medical & Pharmaceutical Co Ltd

I send you an email if I find something interesting about China Resources Sanjiu Medical & Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about China Resources Sanjiu Medical & Pharmaceutical Co Ltd.

Receive notifications about China Resources Sanjiu Medical & Pharmaceutical Co Ltd in your mailbox!